Bank of America’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-633,730
Closed -$1.6M 8400
2023
Q4
$1.6M Buy
633,730
+278,341
+78% +$648K ﹤0.01% 4598
2023
Q3
$849K Sell
355,389
-61,012
-15% -$135K ﹤0.01% 4938
2023
Q2
$962K Sell
416,401
-78,695
-16% -$222K ﹤0.01% 4802
2023
Q1
$1.26M Buy
495,096
+278,763
+129% +$799K ﹤0.01% 4751
2022
Q4
$543K Buy
216,333
+27,286
+14% +$76.1K ﹤0.01% 5322
2022
Q3
$548K Buy
189,047
+118,232
+167% +$498K ﹤0.01% 5325
2022
Q2
$321K Sell
70,815
-202,180
-74% -$1.2M ﹤0.01% 5751
2022
Q1
$2.19M Buy
272,995
+250,995
+1,141% +$2.21M ﹤0.01% 4499
2021
Q4
$256K Sell
22,000
-9,308
-30% -$111K ﹤0.01% 6344
2021
Q3
$388K Buy
+31,308
New +$353K ﹤0.01% 5827

Bank of America's SLGC Position: Q1 2024 in Review

Bank of America sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 633,730 shares — an estimated $1.6M sold.

Bank of America first reported a position in SLGC in Q3 2021 and held it in 10 quarters. The position peaked at $2.19M in Q1 2022. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

  • Bank of America reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • Bank of America sold 633,730 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $1.6M.
  • Bank of America first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 10 quarters.
  • Bank of America's SomaLogic, Inc. Class A Common Stock position peaked at $2.19M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Bank of America's 13F filing for Q1 2024, filed 15 May 2024.